ArticleMolecular therapy : the journal of the American Society of Gene Therapy2012

Bevacizumab with angiostatin-armed oHSV increases antiangiogenesis and decreases bevacizumab-induced invasion in U87 glioma.

Wei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.